This paper studies the immediate and long-run mortality effects of the first communitybased health intervention in the world, which had a particular focus on controlling tuberculosis -the so-called Framingham Health and Tuberculosis Demonstration. Comparing death and TB-mortality rates between Framingham and seven (pre-selected) control towns during the Demonstration period between 1917 and 1923, the contemporary official evaluation committee concluded that the Demonstration was highly successful in controlling TB and reducing mortality The Framingham Demonstration subsequently became a health example for the world. The findings in our paper question this very positive assessment. We collected and digitized causes-of-death data for towns/cities in Massachusetts and the United States for the period 1901-1934, allowing us to extend the number of control towns (or cities) and study whether the Demonstration reduced mortality in the long run. Compared to the official seven controls towns, we find that TB mortality in Framingham was on average lower between 1917 and 1923. In the extended control samples, these immediate TB mortality differences are smaller and often more than reversed by 1934. However, we do find robust evidence that the Demonstration reduced infant mortality, and these improvements persisted even after the Demonstration ended.
This paper studies the immediate and long-run mortality effects of the first communitybased health intervention in the world, which had a particular focus on controlling tuberculosis-the so-called Framingham Health and Tuberculosis Demonstration. Comparing death and TB-mortality rates between Framingham and seven (pre-selected) control towns during the Demonstration period between 1917 and 1923, the contemporary official evaluation committee concluded that the Demonstration was highly successful in controlling TB and reducing mortality The Framingham Demonstration subsequently became a health example for the world. The findings in our paper question this very positive assessment. We collected and digitized causes-of-death data for towns/cities in Massachusetts and the United States for the period 1901-1934, allowing us to extend the number of control towns (or cities) and study whether the Demonstration reduced mortality in the long run. Compared to the official seven controls towns, we find that TB mortality in Framingham was on average lower between 1917 and 1923. In the extended control samples, these immediate TB mortality differences are smaller and often more than reversed by 1934. However, we do find robust evidence that the Demonstration reduced infant mortality, and these improvements persisted even after the Demonstration ended.
This report documents research and analysis conducted as part of a project entitled Timely Monitoring of Sexual Harassment and Gender Discrimination Within the U.S. Army, sponsored by the Office of the Deputy Chief of Staff, G-1, U.S. Army. The purpose of the project was to develop and execute a survey infrastructure to ensure ongoing, timely access to data for monitoring and responding to experiences with sexual harassment and gender discrimination by specific subgroups within the U.S. Army, and to provide additional analysis of secondary data to understand the circumstances surrounding sexual assault and sexual harassment.This research was conducted within RAND Arroyo Center's Personnel, Training, and Health Program. RAND Arroyo Center, part of the RAND Corporation, is a federally funded research and development center (FFRDC) sponsored by the United States Army. RAND operates under a "Federal-Wide Assurance" (FWA00003425) and complies with the Code of Federal Regulations for the Protection of Human Subjects Under United States Law (45 CFR 46), also known as "the Common Rule," as well as with the implementation guidance set forth in U.S. Department of Defense (DoD) Instruction 3216.02. As applicable, this compliance includes reviews and approvals by RAND's Institutional Review Board (the Human Subjects Protection Committee
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.